Benslimane, N.; Loret, C.; Chazelas, P.; Favreau, F.; Faye, P.-A.; Lejeune, F.; Lia, A.-S.
Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons. Pharmaceuticals 2024, 17, 314.
https://doi.org/10.3390/ph17030314
AMA Style
Benslimane N, Loret C, Chazelas P, Favreau F, Faye P-A, Lejeune F, Lia A-S.
Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons. Pharmaceuticals. 2024; 17(3):314.
https://doi.org/10.3390/ph17030314
Chicago/Turabian Style
Benslimane, Nesrine, Camille Loret, Pauline Chazelas, Frédéric Favreau, Pierre-Antoine Faye, Fabrice Lejeune, and Anne-Sophie Lia.
2024. "Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons" Pharmaceuticals 17, no. 3: 314.
https://doi.org/10.3390/ph17030314
APA Style
Benslimane, N., Loret, C., Chazelas, P., Favreau, F., Faye, P.-A., Lejeune, F., & Lia, A.-S.
(2024). Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons. Pharmaceuticals, 17(3), 314.
https://doi.org/10.3390/ph17030314
